To determine the minimal alveolar concentration of hepatic injury patients

To determine the hepatic injury patients' minimal alveolar concentration and analyse the related factors

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001507

Enrollment

Unknown

Registered

2011-08-03

Start date

2011-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

different degree of hepatic injury

Interventions

A1:Sevoflurane

A2:Isoflurane

B1:Sevoflurane

B2:Isoflurane

C1:Sevoflurane

C2:Sevoflurane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suffering hepatic injury in the West China Hospital, Sichuan University

Exclusion criteria

Exclusion criteria: A. patient with history of cardiovascular, respiratory or renal disease B. allergic to any experimental anesthetics C. difficult airway D. alcohol or recreational drug abuse E. psychiatric illness F. a body mass index >30 kg/?

Design outcomes

Primary

Measure	Time frame
Met-enkephalin;MAC of Sevoflurane and Isoflurane under BIS is 50;MAC of Sevoflurane and Isoflurane under Electrical stimulation;	—

Secondary

Measure	Time frame
Electrical stimulation pain threshold;	—

Countries

China

Contacts

Public ContactYan Yin

silver10907@yahoo.com.cn+86 18980601460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026